40 related articles for article (PubMed ID: 28611106)
1. A Novel Combination Treatment Targeting BCL-X
Cho SY; Han JY; Na D; Kang W; Lee A; Kim J; Lee J; Min S; Kang J; Chae J; Kim JI; Park H; Lee WS; Lee C
Mol Cancer Ther; 2017 Oct; 16(10):2178-2190. PubMed ID: 28611106
[TBL] [Abstract][Full Text] [Related]
2. BCL-X
Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
Corcoran RB; Do KT; Kim JE; Cleary JM; Parikh AR; Yeku OO; Xiong N; Weekes CD; Veneris J; Ahronian LG; Mauri G; Tian J; Norden BL; Michel AG; Van Seventer EE; Siravegna G; Camphausen K; Chi G; Fetter IJ; Brugge JS; Chen H; Takebe N; Penson RT; Juric D; Flaherty KT; Sullivan RJ; Clark JW; Heist RS; Matulonis UA; Liu JF; Shapiro GI
Clin Cancer Res; 2024 May; 30(9):1739-1749. PubMed ID: 38456660
[TBL] [Abstract][Full Text] [Related]
4. Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients.
Tsoi H; Lam KC; Dong Y; Zhang X; Lee CK; Zhang J; Ng SC; Ng SSM; Zheng S; Chen Y; Fang J; Yu J
Oncogene; 2017 Nov; 36(44):6109-6118. PubMed ID: 28692053
[TBL] [Abstract][Full Text] [Related]
5. CA-125: an inaccurate surveillance tool immediately after cytoreductive surgery and hyperthermic intraoperative chemotherapy (CRS-HIPEC)?
Shannon NB; Tan GHC; Chia CS; Soo KC; Teo MCC
Int J Hyperthermia; 2018 Aug; 34(5):585-588. PubMed ID: 28683587
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer.
Chang CC; Lin PC; Lin CC; Lan YT; Lin HH; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK; Lin JK; Chang SC
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678173
[TBL] [Abstract][Full Text] [Related]
7. ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer.
Li MZ; Wang JJ; Yang SB; Li WF; Xiao LB; He YL; Song XM
Am J Transl Res; 2017; 9(6):2838-2851. PubMed ID: 28670373
[TBL] [Abstract][Full Text] [Related]
8. Acid-sensing ion channels contribute to the effect of extracellular acidosis on proliferation and migration of A549 cells.
Wu Y; Gao B; Xiong QJ; Wang YC; Huang DK; Wu WN
Tumour Biol; 2017 Jun; 39(6):1010428317705750. PubMed ID: 28618956
[TBL] [Abstract][Full Text] [Related]
9. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments.
Cho SY; Sung CO; Chae J; Lee J; Na D; Kang W; Kang J; Min S; Lee A; Kwak E; Kim J; Choi B; Kim H; Chuang JH; Pak HK; Park CS; Park S; Ko YH; Lee D; Roh J; Cho MS; Park S; Ju YS; Suh YS; Kong SH; Lee HJ; Keck J; Banchereau J; Liu ET; Kim WH; Park H; Yang HK; Kim JI; Lee C
Blood; 2018 Apr; 131(17):1931-1941. PubMed ID: 29475961
[TBL] [Abstract][Full Text] [Related]
11. Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients.
Tsai PC; Lee TH; Kuo KC; Su FY; Lee TM; Marostica E; Ugai T; Zhao M; Lau MC; Väyrynen JP; Giannakis M; Takashima Y; Kahaki SM; Wu K; Song M; Meyerhardt JA; Chan AT; Chiang JH; Nowak J; Ogino S; Yu KH
Nat Commun; 2023 Apr; 14(1):2102. PubMed ID: 37055393
[TBL] [Abstract][Full Text] [Related]
12. Synergistic combination therapy delivered via layer-by-layer nanoparticles induces solid tumor regression of ovarian cancer.
Kong S; Moharil P; Handly-Santana A; Boehnke N; Panayiotou R; Gomerdinger V; Covarrubias G; Pires IS; Zervantonakis I; Brugge J; Hammond PT
Bioeng Transl Med; 2023 Mar; 8(2):e10429. PubMed ID: 36925689
[TBL] [Abstract][Full Text] [Related]
13. CRISPR screens identify a novel combination treatment targeting BCL-X
Jung HR; Oh Y; Na D; Min S; Kang J; Jang D; Shin S; Kim J; Lee SE; Jeong EM; An JY; Sung CO; Lee WS; Lee C; Cho SY
Oncogene; 2021 May; 40(18):3287-3302. PubMed ID: 33846570
[TBL] [Abstract][Full Text] [Related]
14. Turmeric Is Therapeutic
Li M; Yue GG; Luo L; Tsui SK; Fung KP; Ng SS; Lau CB
Front Oncol; 2020; 10():574827. PubMed ID: 33552955
[TBL] [Abstract][Full Text] [Related]
15. Genome-scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotinib-resistant lung cancer.
Lee J; Choi A; Cho SY; Jun Y; Na D; Lee A; Jang G; Kwon JY; Kim J; Lee S; Lee C
Mol Oncol; 2021 Feb; 15(2):487-502. PubMed ID: 33188726
[TBL] [Abstract][Full Text] [Related]
16. Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.
Scherr AL; Mock A; Gdynia G; Schmitt N; Heilig CE; Korell F; Rhadakrishnan P; Hoffmeister P; Metzeler KH; Schulze-Osthoff K; Illert AL; Boerries M; Trojan J; Waidmann O; Falkenhorst J; Siveke J; Jost PJ; Bitzer M; Malek NP; Vecchione L; Jelas I; Brors B; Glimm H; Stenzinger A; Grekova SP; Gehrig T; Schulze-Bergkamen H; Jäger D; Schirmacher P; Heikenwalder M; Goeppert B; Schneider M; Fröhling S; Köhler BC
Cell Death Dis; 2020 Oct; 11(10):875. PubMed ID: 33070156
[TBL] [Abstract][Full Text] [Related]
17. AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA.
Mallick DJ; Eastman A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824203
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2 mediates hypoxia-induced selective mRNA translation via polyamination of 4EBPs.
Cho SY; Lee S; Yeom J; Kim HJ; Lee JH; Shin JW; Kwon MA; Lee KB; Jeong EM; Ahn HS; Shin DM; Kim K; Kim IG
Life Sci Alliance; 2020 Mar; 3(3):. PubMed ID: 32075852
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck.
Carter RJ; Milani M; Butterworth M; Alotibi A; Harper N; Yedida G; Greaves G; Al-Zebeeby A; Jorgensen AL; Schache AG; Risk JM; Shaw RJ; Jones TM; Sacco JJ; Hurlstone A; Cohen GM; Varadarajan S
Cell Death Dis; 2019 Dec; 10(12):912. PubMed ID: 31801952
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
